These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 21685264)

  • 1. Prolonged QT interval and lipid alterations beyond β-oxidation in very long-chain acyl-CoA dehydrogenase null mouse hearts.
    Gélinas R; Thompson-Legault J; Bouchard B; Daneault C; Mansour A; Gillis MA; Charron G; Gavino V; Labarthe F; Des Rosiers C
    Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H813-23. PubMed ID: 21685264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue-specific strategies of the very-long chain acyl-CoA dehydrogenase-deficient (VLCAD-/-) mouse to compensate a defective fatty acid β-oxidation.
    Tucci S; Herebian D; Sturm M; Seibt A; Spiekerkoetter U
    PLoS One; 2012; 7(9):e45429. PubMed ID: 23024820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac tissue citric acid cycle intermediates in exercised very long-chain acyl-CoA dehydrogenase-deficient mice fed triheptanoin or medium-chain triglyceride.
    Gaston G; Gangoiti JA; Winn S; Chan B; Barshop BA; Harding CO; Gillingham MB
    J Inherit Metab Dis; 2020 Nov; 43(6):1232-1242. PubMed ID: 33448436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should the beneficial impact of bezafibrate on fatty acid oxidation disorders be questioned?
    Bastin J; Bonnefont JP; Djouadi F; Bresson JL
    J Inherit Metab Dis; 2015 Mar; 38(2):371-2. PubMed ID: 25310995
    [No Abstract]   [Full Text] [Related]  

  • 5. Development and pathomechanisms of cardiomyopathy in very long-chain acyl-CoA dehydrogenase deficient (VLCAD(-/-)) mice.
    Tucci S; Flögel U; Hermann S; Sturm M; Schäfers M; Spiekerkoetter U
    Biochim Biophys Acta; 2014 May; 1842(5):677-85. PubMed ID: 24530811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De novo fatty acid biosynthesis and elongation in very long-chain acyl-CoA dehydrogenase-deficient mice supplemented with odd or even medium-chain fatty acids.
    Tucci S; Behringer S; Spiekerkoetter U
    FEBS J; 2015 Nov; 282(21):4242-53. PubMed ID: 26284828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A heterozygous missense mutation in adolescent-onset very long-chain acyl-CoA dehydrogenase deficiency with exercise-induced rhabdomyolysis.
    Hisahara S; Matsushita T; Furuyama H; Tajima G; Shigematsu Y; Imai T; Shimohama S
    Tohoku J Exp Med; 2015 Apr; 235(4):305-10. PubMed ID: 25843429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AAV9 gene replacement therapy for respiratory insufficiency in very-long chain acyl-CoA dehydrogenase deficiency.
    Zieger M; Keeler AM; Flotte TR; ElMallah MK
    J Inherit Metab Dis; 2019 Sep; 42(5):870-877. PubMed ID: 30993714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disrupted fat distribution and composition due to medium-chain triglycerides in mice with a β-oxidation defect.
    Tucci S; Flögel U; Sturm M; Borsch E; Spiekerkoetter U
    Am J Clin Nutr; 2011 Aug; 94(2):439-49. PubMed ID: 21697078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term correction of very long-chain acyl-coA dehydrogenase deficiency in mice using AAV9 gene therapy.
    Keeler AM; Conlon T; Walter G; Zeng H; Shaffer SA; Dungtao F; Erger K; Cossette T; Tang Q; Mueller C; Flotte TR
    Mol Ther; 2012 Jun; 20(6):1131-8. PubMed ID: 22395529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue acylcarnitine status in a mouse model of mitochondrial β-oxidation deficiency during metabolic decompensation due to influenza virus infection.
    Tarasenko TN; Cusmano-Ozog K; McGuire PJ
    Mol Genet Metab; 2018 Sep; 125(1-2):144-152. PubMed ID: 30031688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac-specific VLCAD deficiency induces dilated cardiomyopathy and cold intolerance.
    Xiong D; He H; James J; Tokunaga C; Powers C; Huang Y; Osinska H; Towbin JA; Purevjav E; Balschi JA; Javadov S; McGowan FX; Strauss AW; Khuchua Z
    Am J Physiol Heart Circ Physiol; 2014 Feb; 306(3):H326-38. PubMed ID: 24285112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies for correcting very long chain acyl-CoA dehydrogenase deficiency.
    Tenopoulou M; Chen J; Bastin J; Bennett MJ; Ischiropoulos H; Doulias PT
    J Biol Chem; 2015 Apr; 290(16):10486-94. PubMed ID: 25737446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Very long-chain acyl-CoA dehydrogenase (VLCAD-) deficiency-studies on treatment effects and long-term outcomes in mouse models.
    Tucci S
    J Inherit Metab Dis; 2017 May; 40(3):317-323. PubMed ID: 28247148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management and diagnosis of mitochondrial fatty acid oxidation disorders: focus on very-long-chain acyl-CoA dehydrogenase deficiency.
    Yamada K; Taketani T
    J Hum Genet; 2019 Feb; 64(2):73-85. PubMed ID: 30401918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Food withdrawal lowers energy expenditure and induces inactivity in long-chain fatty acid oxidation-deficient mouse models.
    Diekman EF; van Weeghel M; Wanders RJ; Visser G; Houten SM
    FASEB J; 2014 Jul; 28(7):2891-900. PubMed ID: 24648546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fasting-induced oxidative stress in very long chain acyl-CoA dehydrogenase-deficient mice.
    Tucci S; Primassin S; Spiekerkoetter U
    FEBS J; 2010 Nov; 277(22):4699-708. PubMed ID: 20883455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The fate of medium-chain fatty acids in very long-chain acyl‑CoA dehydrogenase deficiency (VLCADD): A matter of sex?
    Wehbe Z; Alatibi K; Jellusova J; Spiekerkoetter U; Tucci S
    Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Nov; 1864(11):1591-1605. PubMed ID: 31394165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic and muscular effects of different dietary fat content in VLCAD deficient mice.
    Primassin S; Tucci S; Spiekerkoetter U
    Mol Genet Metab; 2011 Dec; 104(4):546-51. PubMed ID: 21963783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and biochemical outcome of patients with very long-chain acyl-CoA dehydrogenase deficiency.
    Rovelli V; Manzoni F; Viau K; Pasquali M; Longo N
    Mol Genet Metab; 2019 May; 127(1):64-73. PubMed ID: 31031081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.